Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Psychosis , broadly defined, is a gross impairment of reality testing. Psychosis can result from a wide range of psychiatric and medical disturbances and may take several forms. The elderly woman, who lies quietly in bed listening to Satan whisper, bears little resemblance to the wildly agitated young man who accuses the nursing staff of trying to poison him. Hallucinations and delusions are the two classic psychiatric symptoms whose presence would indicate that the patient has lost touch with reality (i.e., suffers from psychosis). Hallucinations, which are sensory perceptions in the absence of an external source, can occur in any sensory modality and may take the form of voices, visions, odors, or even complex tactile perceptions (such as electric shocks, or the sensation that one is being fondled). Delusions are firmly held beliefs that other members of the patient's societal group would judge to be false. Delusions range from beliefs that are plausible, albeit unlikely (such as being monitored by the National Security Agency), to bizarre convictions (e.g., that one's internal organs have been replaced with empty beer cans). Delusional individuals cling to their beliefs with unfaltering conviction even in the face of overwhelming evidence to the contrary. Another category of psychotic symptoms comes under the rubric of a formal thought disorder, which refers to a disruption in the form, or organization, of thinking. Patients with a formal thought disorder may be incoherent to the point of producing word salad; they may not be able to make sense of reality or to communicate their thoughts to others.
When called to see a patient with psychosis, the psychiatric consultant can be of immediate help by ensuring that the patient and staff are safe; moreover, he or she can demystify this often-frightening condition. Psychosis can best be approached by proceeding with a well-ordered differential diagnosis, which transforms the patient's condition in the eyes of medical staff from insanity, with all its disturbing connotations, to a more comprehensible disorder of brain function.
Mr. A, a 45-year-old man who lived in a group home for patients with serious mental illness, had been going to a community mental health center for his psychiatric care. He had long-standing schizophrenia that had been treated with clozapine for 10 years. Mr. A was brought to the Emergency Department for abdominal pain. He was admitted to the surgical service for an acute abdomen and found to have a toxic megacolon that required a hemicolectomy.
Psychiatry was consulted to help manage Mr. A's medications and perioperative agitation. Clozapine was held and haloperidol was used to manage agitation. Even though his prior treatment with clozapine contributed to the development of toxic megacolon (because of clozapine's anticholinergic properties), the patient and his family considered clozapine an essential medication, as it had stabilized his illness course after a decade of failed treatments with other antipsychotics. Clozapine was therefore re-started at a low dose and carefully titrated to his previous dose during the hospitalization.
The hospitalization was also used to address two other concerns: Mr. A's basic medical care and his nicotine use. Mr. A had not seen his primary care doctor in many years, and he had been smoking cigarettes since high school, currently smoking two packs per day. Thus, the psychiatric consultant requested basic screening laboratory tests (i.e., hemoglobin A 1c and lipid profile) to assess for metabolic side effects that can emerge from long-term treatment with clozapine. His hemoglobin A 1c was found to be elevated but pre-diabetic. In addition, Mr. A received nicotine patches during the hospitalization to manage nicotine withdrawal and the psychiatric consultant used motivational interviewing to engage Mr. A around smoking cessation as a critical health goal to reduce his cardiovascular mortality risk. Follow-up with a primary care doctor to address diabetes prevention was arranged as part of his hospital discharge plan. Mr. A also agreed to start a smoking cessation group at his community mental health center and discuss pharmacotherapy for smoking cessation (e.g., varenicline) with his outpatient psychiatrist. Last, the group home received a note from the psychiatry consultation-liaison service about the prevention of constipation in clozapine patients. As a result of this hospital admission, Mr. A became more engaged in managing his own medical health and better linked to healthcare services.
It cannot be stressed enough that the presence of psychotic symptoms does not always mean that a primary psychiatric disorder like schizophrenia is present. Therefore, the diagnostic assessment of a psychotic patient begins with a thorough consideration of toxic or medical conditions that can present with psychosis ( Table 12-1 ). A medical history, review of systems, family history, and physical examination are crucial elements of this process because most organic causes can be identified on this basis. A bedside examination of cognitive function should be performed. The Mini-Mental State Examination supplemented by the clock-drawing test will usually suffice as an initial cognitive screen. Serious deficits in attention, orientation, and memory suggest delirium or dementia rather than a primary psychotic illness. However, only more comprehensive neurocognitive testing will establish the more subtle yet functionally relevant cognitive difficulties with processing speed, working memory, verbal memory, and executive function that almost all patients with schizophrenia, including first-episode patients, experience to some degree. Careful delineation of the temporal course of psychotic symptoms is of particular diagnostic importance. History from family about the patient is often the most critical aspect for piecing together how the illness unfolded over time. One should consider whether the disorder is chronic, episodic, or of recent onset. A typical prodromal period of unspecific anxiety and depression for several months followed by attenuated psychotic symptoms and increasing role failure that eventually gives rise to psychosis at the syndromal level is a typical time course for beginning schizophrenia. The temporal relationship of psychotic symptoms to mood episodes, substance use, medication use, and medical or neurologic illness should be carefully reviewed. Substance misuse, such as intoxication with stimulants or synthetic cannabinoids, is potentially reversible and in the latter case an increasingly common cause of psychosis that leads to emergency room visits. Many other illegal drugs and legal medications have the potential to cause psychosis; unfortunately, causality is often difficult to prove ( Table 12-2 ). Such substance-induced psychoses should be considered if the psychosis is of new onset, if there is no personal history of psychosis, or if the psychosis starts in the hospital, particularly if a delirium is present. A urine toxicologic screening test might identify unsuspected drug use, but it would not rule out drug-induced psychosis if it were negative, nor would a positive toxicologic screening test necessarily establish a cause for the psychosis, because co-morbid substance use and abuse is common in psychotic disorders. Many designer drugs that are freely available over the Internet require specialized and dedicated testing that is usually not available. Routine laboratory testing includes determination of a sedimentation rate, a complete blood cell count, serum electrolytes, urinalysis, and levels of calcium, glucose, creatinine, and blood urea nitrogen. In addition, liver function tests, thyroid function tests, and syphilis serology (specific, such as the fluorescent treponemal antibody absorption test), are appropriate. Human immunodeficiency virus (HIV) testing should be recommended. Extended work-ups may include karyotyping for chromosomal abnormalities or urine testing for metabolic disorders. The diagnostic yield from neuroimaging of the brain (magnetic resonance imaging, MRI; or computed tomography, CT) is low in the absence of localizing neurologic findings. Neuroimaging should be obtained, however, in cases with atypical or unresponsive psychotic symptoms when psychotic symptoms first appear and should be considered even in cases with typical psychotic features, because the long-term costs and morbidity of this disorder are potentially quite high in relation to the expense of diagnostic procedures. The electroencephalogram (EEG) can be useful when evaluating a confused patient where a delirium is suspected or when a history of serious head trauma or symptoms suggestive of a seizure disorder are present. An EEG is rarely helpful if it is employed as a routine screening procedure. Similarly, a lumbar puncture is not necessary for a routine work-up, but it can be lifesaving if a treatable central nervous system (CNS) infection is suspected. NMDA receptor encephalitis is a newly delineated autoimmune disorder of particular concern to psychiatrists since patients might initially present with only psychiatric symptoms. Making this diagnosis quickly is critical to initiate immunotherapy and requires a lumbar puncture to detect NMDA receptor antibodies.
Epilepsy
Head trauma (history of)
Dementias
Alzheimer's disease
Pick's disease
Lewy body disease
Stroke
Space-occupying lesions and structural brain abnormalities
Primary brain tumors
Secondary brain metastases
Brain abscesses and cysts
Tuberous sclerosis
Midline abnormalities (e.g., corpus callosum agenesis, cavum septi pellucidi)
Cerebrovascular malformations (e.g., involving the temporal lobe)
Hydrocephalus
Demyelinating diseases
Multiple sclerosis
Leukodystrophies (metachromatic leukodystrophy, X-linked adrenoleukodystrophy, Marchiafava–Bignami disease)
Schilder's disease
Neuropsychiatric disorders
Huntington's disease
Wilson's disease
Parkinson's disease
Friedreich's ataxia
Autoimmune disorders
Systemic lupus erythematosus
Rheumatic fever (history of)
Paraneoplastic syndromes
Myasthenia gravis
NMDA receptor encephalitis
Infections
Viral encephalitis (e.g., herpes simplex, measles including SSPE, cytomegalovirus, rubella, Epstein–Barr, varicella)
Neurosyphilis
Neuroborreliosis (Lyme disease)
HIV infection
CNS-invasive parasitic infections (e.g., cerebral malaria, toxoplasmosis, neurocysticercosis)
Tuberculosis
Sarcoidosis
Cryptococcus infection
Prion diseases (e.g., Creutzfeldt–Jakob disease)
Endocrinopathies
Hypoglycemia
Addison's disease
Cushing's syndrome
Hyperthyroidism and hypothyroidism
Hyperparathyroidism and hypoparathyroidism
Hypopituitarism
Narcolepsy
Nutritional deficiencies
Magnesium deficiency
Vitamin A deficiency
Vitamin D deficiency
Zinc deficiency
Niacin deficiency (pellagra)
Vitamin B 12 deficiency (pernicious anemia)
Metabolic disorders
Amino acid metabolism (Hartnup disease, homocystinuria, phenylketonuria)
Porphyrias (acute intermittent porphyria, porphyria variegata, hereditary coproporphyria)
GM 2 gangliosidosis
Fabry's disease
Niemann–Pick type C disease
Gaucher's disease, adult type
Chromosomal abnormalities
Sex chromosomes (Klinefelter's syndrome, XXX syndrome)
Fragile X syndrome
VCFS
CNS, central nervous system; HIV, human immunodeficiency virus; SSPE, subacute sclerosing panencephalitis; VCFS, velo-cardio-facial syndrome.
Alcohol
Amphetamine
Anabolic steroids
Cannabis including synthetic cannabinoids
Cocaine
Designer drugs (wide variety of chemical classes)
Hallucinogens: LSD, MDMA
Inhalants: glues and solvents
Opioids (meperidine)
Phencyclidine (PCP), ketamine
Sedative–hypnotics (including withdrawal): barbiturates and benzodiazepines
Alcohol
Sedative–hypnotics
Anesthetics and analgesics (including NSAIDs)
Anticholinergic agents and antihistamines
Antiepileptics (with high doses)
Antihypertensive and cardiovascular medications (e.g., digoxin)
Anti-infectious medications (antibiotics, e.g., fluoroquinolones, TMP/SMX; antivirals, e.g., nevirapine; tuberculostatics, e.g., INH; antiparasitics, e.g., metronidazole, mefloquine)
Antiparkinsonian medications (e.g., amantadine, levodopa)
Chemotherapeutic agents (e.g., vincristine)
Corticosteroids (e.g., prednisone, ACTH)
Interferon
Muscle relaxants (e.g., cyclobenzaprine)
Over-the-counter medications (e.g., pseudoephedrine, caffeine in excessive doses)
Carbon monoxide
Heavy metals: arsenic, manganese, mercury, thallium
Organophosphates
Does the patient have a history of psychosis?
Does the patient have a history of illicit drug use?
Did the psychosis start after a medication was started? After the patient came to the hospital?
Is there evidence of delirium?
ACTH, adrenocorticotropic hormone; INH, isoniazid; LSD, D-lysergic acid diethylamide; MDMA, methylenedioxymethamphetamine; NSAID, non-steroidal antiinflammatory drug; TMP/SMX, trimethoprim/sulfamethoxazole.
Several neuropsychiatric disorders in particular should be considered during the diagnostic work-up of a patient with psychosis. Huntington's disease is suggested by family history of Huntington's disease, dementia, and choreiform movements; psychotic symptoms may occur before motor and cognitive symptoms become prominent. Parkinson's disease also may present with psychosis, along with bradykinesia, tremor, rigidity, and a festinating gait. With disease progression, psychosis is common and can be the result of illness and not just of medications. The diagnosis of Parkinson's disease can be complicated by exposure to neuroleptics—review of the time course of neurologic symptoms in relation to the use of antipsychotics should clarify this diagnostic possibility. Wilson's disease may also present with psychotic symptoms, tremor, dysarthria, rigidity, and a gait disturbance. Kayser–Fleischer rings, which are golden-brown copper deposits that encircle the cornea, are pathognomonic for this disease. However, a slit-lamp exam is needed to detect them early on. The diagnosis can be confirmed by measuring concentrations of ceruloplasmin in the urine and serum. Finally, acute intermittent porphyria is characterized by acute episodes of abdominal pain, weakness, and peripheral neuropathy; this condition may be associated with psychosis. Because this is a hereditary (autosomal dominant) illness, a family history often points to this diagnosis. During acute attacks, levels of δ-aminolevulinic acid and porphobilinogen are elevated in the urine.
It is impractical and ill-advised to attempt to rule out all conceivable diseases that could cause psychosis. The more tests are ordered without clinical concern for a particular disease, the more false-positive test results will occur. Thankfully, a thoughtful approach that combines clinical history and a physical examination (including a neurologic examination) with selected laboratory tests will usually suffice to exclude treatable medical illnesses and provide a medical baseline for future reference. Table 12-3 suggests one screening battery that accomplishes these important initial diagnostic goals.
Physical exam with emphasis on neurologic exam
Vital signs
Weight and height (BMI), waist circumference a
a Not for diagnostic purposes but to establish baseline for longitudinal medical monitoring.
Electrocardiogram (ECG) a
Complete blood count (CBC)
Electrolytes including calcium
Renal function tests (BUN/creatinine)
Liver function tests
Erythrocyte sedimentation rate (ESR)
Antinuclear antibody (ANA)
Fasting glucose
Fasting lipid profile a
Hemoglobin A 1c a
Consider prolactin level a
Hepatitis C (if risk factors are present) a
Pregnancy test (in women of childbearing age)
Urine drug screen
Thyroid stimulating hormone (TSH)
Fluorescent treponemal antibody absorbed (FTA-ABS)
HIV test
Ceruloplasmin
Vitamin B 12
MRI (preferred over CT)
Expand etiological search if indicated, taking into account epidemiology: e.g., chest x-ray, electroencephalogram (EEG), lumbar puncture, karyotype, heavy metal testing, Lyme antibodies, NMDA receptor autoantibodies, and other autoantibodies
Expand medical monitoring if indicated: e.g., eye exam (if risk factors for cataracts are present)
After an organic cause has been ruled out, the psychiatric differential diagnosis of psychosis flows from the diagnostic criteria contained in the “Psychotic Disorders” section of the Diagnostic and Statistical Manual of Mental Disorders , 5th edition (DSM-5). It should be emphasized, however, that these criteria are guidelines for diagnosis and a tool for a common language; they are to be used only in conjunction with a full understanding of the descriptions of the syndrome as described in textbooks ( Table 12-4 ). A clear, longitudinal view of the illness is necessary to identify affective episodes and to determine whether the patient's level of function has declined. In addition, the range and severity of psychotic and negative symptoms as well as the neurocognitive impairment must be determined. Psychotic patients are often unable to provide an accurate history; therefore information must be collected from as many sources as possible. In one study, information necessary for diagnosis, such as the presence of persecutory delusions, was missed more than 30% of the time when the assessment was based on the interview only. Concurrent substance abuse is also frequently missed in patients with schizophrenia if toxicologic screening is not performed.
Schizophrenia
Schizoaffective disorder, bipolar type (with prominent episodes of mania)
Schizoaffective disorder, depressed type (with prominent depressive episodes)
Delusional disorder (plausible, circumscribed delusions)
Shared psychotic disorder (in which delusions are induced by another person)
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here